Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LUNA: Landiolol use in mitral valve surgery
2024-515934-34-00Phase 4Authorised
- Sponsor
- IRCCS Ospedale San Raffaele
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in low cardiac output syndrome (LCOS) comparing Landiobloc arm with Placebo arm (2 arms). Primary endpoint: Postoperative low-cardiac output syndrome incidence. Planned start Jan 2025; status: authorised.
02
Drugs
landiolol
03
Conditions
low cardiac output syndrome (LCOS)
Beyond the preview
Go deeper on 2024-515934-34-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-515934-34-00.